Academics, Anesthesiologists, Cardiologists, Caregivers, Clinical Pharmacologists, Clinicians, Dermatologists, Endocrinologists, General Practitioners, Gynecologists, Healthcare Executives, Hepatologists, Infectious Disease Specialists, Ophthalmologists, Outcomes Manager, Pain Specialists, Patients, Pediatricians, Pharmaco-Epidemiologists, Pharmacologists, Primary Care Physicians, Researchers, Rheumatologists
Clinical Drug Investigation provides rapid publication of original research covering all phases of clinical drug development and therapeutic use of drugs. The Journal includes:
- Clinical trials, outcomes research, clinical pharmacoeconomic studies and pharmacoepidemiology studies with a strong link to optimum prescribing practice for a drug or group of drugs.
- Clinical pharmacodynamic and clinical pharmacokinetic studies with a strong link to clinical practice.
- Pharmacodynamic and pharmacokinetic studies in healthy volunteers in which significant implications for clinical prescribing are discussed.
- Studies focusing on the application of drug delivery technology in healthcare.
- Short communications and case study reports that meet the above criteria will also be considered.
Additional enhanced features (including slide sets, videos and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in Clinical Drug Investigation may be accompanied by plain language summaries to assist readers in understanding important medical advances. All manuscripts are subject to peer review by international experts. Letters to the Editor are welcomed and will be considered for publication.
"Clinical Drug Investigation covers:
- Clinical trials
- Outcomes research
- Pharmacoeconomics studies
- Pharmacoepidemiology studies
- Pharmacodynamic and pharmacokinetic studies
- Application of drug-delivery technology in healthcare
The journal Also offers the ability to create digital features as well as host them.